IP Library Assignment 031212/0891
Patent Assignment
Reel/Frame 031212/0891

Assignment of Assignor's Interest

Recorded: 2013-09-16 Pages: 10
Assignors
DYMOCK, BRIAN WILLIAM
Executed: 2006-08-22
DRYSDALE, MARTIN JAMES
Executed: 2006-05-22
FROMONT, CHRISTOFE
Executed: 2006-05-15
JORDAN, ALLAN
Executed: 2006-05-16
BARRIL-ALONSO, XAVIER
Executed: 2006-05-24
Assignees
VERNALIS (CAMBRIDGE) LIMITED
GRANTA PARK, ABINGTON, CAMBRIDGE, CB1 6GB, UNITED KINGDOM
CANCER RESEARCH TECHNOLOGY LTD.
61 LINCOLN'S INN FIELDS, LONDON, WC2A 3PX, UNITED KINGDOM
THE INSTITUTE OF CANCER RESEARCH
ROYAL CANCER HOSPITAL, 123 OLD BROMPTON ROAD, LONDON, SW7 3RP, UNITED KINGDOM
BARRIL-ALONSO, XAVIER
C/O VERNALIS (CAMBRIDGE) LIMITED, GRANTA PARK, ABINGTON, CAMBRIDGE, CB1 6GB, UNITED KINGDOM
Covered Property (1)
Substituted Thieno[2,3-D]Pyrimidines as HSP90 Inhibitors
Patent: 8,642,594 →
Application: 12/690,983 →
Publication: US 2010/0120767
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 12, 2012
From: VERNALIS (CAMBRIDGE) LIMITED
To: VERNALIS (R&D) LIMITED
Reel/Frame 029450/0945 →